No in vivo experiments, such as subcutaneous xenografts, were performed to evaluate the effects of IKBKE knockdown on tumor growth, pharmacological response, or Ki-67/LC3-II expression in tumor tissues. This evidence concerns the gene MKI67 and neoplasm.